For the sake of argument...

Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
Post Reply
biopearl123
Posts: 646
Joined: Fri Jul 20, 2018 5:13 pm

For the sake of argument...

Post by biopearl123 » Thu Jul 15, 2021 9:12 pm

So for the sake of argument, lets assume Geron did raise during the mystery volume day and say now has 300 M in the bank. Current market cap is 390. So enterprise value is 90M. That is about one month and half of projected sales of Imetelstat in the MDS market. 100% enrollment probably by the end of Sept, then 15 months to top line data. (Recall that data analysis is ongoing from the time of intention to treat so a lot of data will be available even by the time the last patient is enrolled, also recall the DSMB has allowed the study to go forward suggesting nothing negative in the analysis so far. the DSMB will not stop the study for efficacy only for safety. The study goes for 15 months from the time the last patient is enrolled. So with that market cap and the known excellent data presented so far, would you not wait say 18 months for a major breakout from these values? bp

biopearl123
Posts: 646
Joined: Fri Jul 20, 2018 5:13 pm

Re: For the sake of argument...

Post by biopearl123 » Thu Jul 15, 2021 9:14 pm

Well my math is faulty since it didn't take into consideration potential dilution in assumption of number of shares outstanding. My bad.

Post Reply